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Purpose: To characterize the molecular defects in the TGFBI gene in a Chinese family with an unusual phenotype of
Reis-Bücklers corneal dystrophy (RBCD).
Methods: Three generations of the family with RBCD were enrolled in the present study. In addition to ophthalmologic
examinations, polymerase chain reaction (PCR) amplification and nucleotide sequencing of exons of TGFBI were
performed. Exon 14 was also sequenced in 100 healthy controls unrelated to the family for comparison.
Results: The clinical features of the disease were characterized by geographic opacities in the anterior to mid stroma of
the cornea. Molecular genetic analysis revealed a heterozygous point mutation at exon 14 (c.1915 G>A) in all affected
members of the family. The unusual opacities involving the anterior to mid-cornea stroma were different from the
phenotypic features of families previously reported to have the same genetic change.
Conclusions: We speculate that this disorder is a variant of RBCD. This finding may expand our knowledge about RBCD
and facilitate diagnosis of corneal dystrophies associated with atypical clinical features.
Corneal  dystrophy  is  a  group  of  hereditary  disorders
characterized by bilateral abnormal deposition in different
layers of the cornea which may impair corneal transparency
and  refraction  [1].  Most  of  the  corneal  dystrophies  are
inherited  as  autosomal  dominant  traits  with  extensive
intrafamily and interfamily variations in clinical phenotypes
[2].  The  transforming  growth  factor  beta  induced  gene
(TGFBI, OMIM 601692), located on chromosome 5q31, has
been linked to many types of corneal dystrophy including
lattice corneal dystrophy of types I, IIIA, I/IIIA, IIIB, and IV,
granular  corneal  dystrophy  type  I,  Avellino  corneal
dystrophy,  Thiel-Behnke  dystrophy,  and  Reis-Bücklers
dystrophy [3-8]. Particular mutations in TGFBI are frequently
linked to special corneal dystrophy, but a genotype-phenotype
correlation is not always certain [9-12]. Atypical and variable
phenotypes have made it difficult to accurately diagnose and
classify the corneal dystrophies particularly for patients with
equivocal or ambiguous findings in the clinic.
Reis-Bücklers  corneal  dystrophy  (RBCD,  OMIM
608470) is a dominantly inherited dystrophy that primarily
affects  Bowman’s  layer  and  is  characterized  by  frequent
recurrence,  painful  corneal  erosions,  superficial  corneal
opacities, and significant visual impairment [13,14]. To date,
four different mutations in TGFBI have been found to be
associated with most cases of RBCD [15-17].
RBCD is relatively rare in China, and limited studies have
been reported [18,19]. Thus far, the R124L mutation in TGFBI
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is the only one found to be associated with this type of corneal
dystrophy in Chinese patients. In this study, we describe a
Chinese  consanguineous  family  with  an  atypical  RBCD
possibly  caused  by  the  p.G623D  mutation.  The  unusual
opacities  involving  the  anterior  to  mid-cornea  stroma  are
different  from  the  phenotype  previously  reported  for  this
Figure 1. Pedigree of the proband’s family. Autosomal dominant
transmission  of  the  disease  is  evident.  An  asterisk  indicates  the
subject  underwent  clinical  and  molecular  analyses.  Black/closed
symbols  represent  the  affected  members.  The  arrow  signals  the
proband.
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1298mutation. We propose that this particular disorder may be a
variant  of  RBCD.  This  finding  expands  the  genotypic-
phenotypic spectrum of RBCD and may facilitate diagnosis
of this disease in future.
METHODS
Patients and controls: We studied a three-generation Chinese
family  with  RBCD  from  the  Heilongjiang  province  in
northeastern China (Figure 1). Four patients, two non-carrier
relatives, and 100 healthy unrelated normal controls were
recruited in this study. The study was approved by a local
institutional review board, and informed consent was obtained
from  each  of  the  participants.  All  subjects  underwent
ophthalmologic  evaluation  including  best  corrected  visual
acuity, slit lamp, and fundus examination.
Genetic  analysis:  Blood  samples  were  drawn  by
venipuncture,  and  genomic  DNA  was  extracted  using  the
TIANamp Blood DNA Kit (Tiangen Biltech Co. Ltd, Beijing,
China). All exons of TGFBI were amplified by polymerase
chain reaction (PCR) using the primers described previously
[8,20-22]. The sequences of the primers are listed in Table 1.
The PCR amplification reaction mixture (50 μl) contained
10X PCR buffer, 10–200 ng of genomic DNA, 0.2 mM of each
dNTP, 1 unit of Taq polymerase, and 1 μl of 1 mM forward
and reverse primers. The thermocycling procedure included
an initial denaturation step at 95 °C for 5 min followed by 35
TABLE 1. PRIMERS   USED   FOR   TGFBI   AMPLIFICATION.
Exon Sequences (5′-3′) Annealing Temp
(°C)
Reference
1 F: GCGCTCTCACTTCCCTGGAG 53 [8]
R: GACTACCTGACCTTCCGCAG
2 F: GGTGGACGTGCTGATCATCT 55 [8]
R: AGCCAGCGTGCATACAGCTT
3 F: ACCTGTGAGGAACAGTGAAG 55 [22]
R: GCCTTTTATGTGGGTACTCC
4 F: CCCCAGAGGCCATCCCTC CT 59 [3]
R: CCGGGCAGACGGAGGTCATC
5 F: TAAACACAGAGTCTGCAGCC 55 [21]
R: TTCATTATGCACCAAGGGCC
6 F: TGTGTTGACTGCTCATCCTT 50 [21]
R: CATTCAGGGGAACCTGCTCT
7 F: TTCAGGGAGCACTCCATCTT 55 [21]
R: ATCTAGCGCACAAATGAGG
8 F: CTTGACCTGAGTCTGTTTGG 53 [8]
R: GAAGTCGCCCAAAGATCTCT
9 F: ACTTTTGAACCCACTTTCTC 55 [21]
R: CAATCTAACAGGGATGCCTT
10 F: TCTGGACCTAACCATCACCC 55 [21]
R: CAGGAGCATGATTTAGGACC
11 F: CTCGTGGAAGTATAACCAGT 55 [3]
R: TGGGCAGAAGCTCCACCCGG
12 F: CATTCCAGTGGCCTGGACTCTACTATC 58 [3]
R: GGGGCCCTGAGGGATCACTACTT
13 F: GGGATTAACTCTATCTCCTT 50 [8]
R: TGTGTATAATTCCATCCTGG
14 F: CTGTTCAGTAAACACTTGCT 55 [3]
R: CTCTCCACCAACTGCCACAT
15 F: CACTCTGGTCAAACCTGCCT 55 [21]
R: AGGCTAGGCGCAAACCTAGC
16 F: CAGTTGCAGGTATAACTTTC 58 [21]
R: TAAACAGGTGTGCAATGACT
17 F: GGGAGATCTGCACCTATTTG 55 [8]
R: TGGTGCATTCCTCCTGTAGT
Summary of the primers and annealing temperatures used for
the amplification of the 17 exons of TGFBI.
cycles of denaturation, annealing, and extension. The primer
annealing temperatures are shown in Table1, and the terminal
extension step was accomplished at 72 °C for 10 min. The
PCR products were purified with a TIANgel Midi Purification
Kit (Tiangen Biltech Co. Ltd, Beijing, China) and sequenced
with an ABI BigDye Terminator Cycle Sequencing kit v3.1,
(ABI Applied Biosystems, Foster City, CA).
RESULTS
Clinical findings: The proband (Patient IV: 1, Figure 1) was
a  56-year-old  woman  who  was  the  offspring  of  a
consanguineous  marriage.  She  had  experienced  defective
vision along with corneal erosion since the age of 32. Corneal
examination revealed multiple opacities in subepithelial and
anterior stroma in the central cornea of the left eye (Figure
2A).  In  the  right  eye,  a  gray-white  geographic  opacity
involving the anterior and mid stroma of the cornea with clear
borders was noted (Figure 2B). Patient IV:3, the 53-year-old
sister of the proband, was diagnosed with the disease at age
30. Anterior segment evaluation revealed geometric opacities
mixed with round haze in the anterior stroma and subepithelial
layers of the central cornea in both eyes (Figures 2C,D). Two
other subjects evaluated were from the fifth generation (V:1
and V:3; 33 and 31 years old, respectively) and had no clinical
symptoms but manifested diffuse, small dot epithelial and
subepithelial  opacities  bilaterally  in  the  central  cornea
(Figures 2E,F). V:7 and VI:3 did not show any clinical sign
of corneal dystrophy.
TGFBI mutation analysis: After direct sequencing of exons of
TGFBI, a single heterozygous G>A mutation at nucleotide
position 1915 in exon 14 of TGFBI (codon 623) was detected
(Figure  3).  This  resulted  in  a  glycine  to  aspartic  acid
Figure  2.  Clinical  photography  of  corneas  in  affected  family
members. A and B: Slit lamp photographs of the proband show
multiple opacities in the subepithelial and anterior stromal regions
in the central cornea of the left eye (A) and geographical opacity
involving the anterior and mid stroma in the right eye (B). C and
D: Corneal images of patient IV:3 revealed geometric and round
opacities involving the anterior stroma and subepithelial layers in
both eyes. E and F: Corneal images of V:1 and V:3 are shown,
respectively. Dot epithelial and subepithelial opacities were noted.
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1299substitution at the protein level. None of the healthy family
members or any of the 100 control subjects was positive for
this mutation.
DISCUSSION
To date, four distinct autosomal dominant Bowman’s layer/
stromal  corneal  dystrophies  have  been  linked  to  various
mutations  in  TGFBI.  A  phenotype-genotype  correlation
between specific types of corneal dystrophies and particular
TGFBI mutations has been established among these patients
[23]. However, corneal dystrophies also sometimes display a
wide range of clinical manifestations even when the same
single point mutation is involved [3,9-12]. The variations in
phenotype  and  penetrance  can  lead  to  difficulties  in
classification,  diagnosis,  and  pathological  study  of  these
diseases. In this study, we demonstrated an unusual form of
RBCD associated with the p.G623D mutation in TGFBI.
Three  families  with  the  p.G623D  mutation  were
previously  described  in  the  literature  [3,8,24].  In  2001,
Afshari et al. [8] first described a family with RBCD caused
by  the  p.G623D  mutation.  The  patient  had  a  history  of
recurrent painful corneal erosion since childhood and showed
geographic  subepithelial  corneal  opacities.  The  following
year, Munier et al. [3] reported on another family carrying the
same mutation. However, based on the late onset of the disease
and the presence of tiny linear deposits in the anterior stroma,
this type of corneal dystrophy has been reclassified as lattice
corneal  dystrophy  I/IIIA.  An  additional  family  with  the
p.G623D mutation was described by Aldave et al. in 2004
[24]. The family had a unique corneal dystrophy involving
Bowman’s layer and the corneal stroma. Affected members
had subepithelial haze mixed with lattice line-like opacities in
the anterior stroma.
The pedigree reported herein was from a consanguineous
marriage. The proband had a gray-white geographic opacity
in the anterior to mid stroma of her right eye. In addition,
geometric and round opacities involving the anterior stroma
Figure 3. Partial nucleotide sequence of TGFBI exon 14. A: The
sequence  in  an  affected  subject  shows  a  heterozygous  G>A
transversion (indicated by the arrow). The nucleotide substitution at
codon 623 resulted in a change from glycine (GGC) to aspartic acid
(GAC). B: Unaffected family members and the control subjects
lacked this nucleotide change.
and subepithelial layers were also found in both the proband
and her sister. The clinical features including recurrent erosion
and gradually developing opacities of Bowman’s layer were
identical to the characteristics of RBCD [13,14] and to those
found in the families described previously by Afshari et al.
[8] and Aldave et al. [24]. However, no lattice lines were noted
in the proband or other affected members, and the deposits
were located in the mid stroma of the cornea, which was
different from the phenotypes previously reported for this
mutation. Thus, we propose that this particular disorder may
be a variant of RBCD.
The  protein  encoded  by  TGFBI  is  βig-h3  (TGFBIp,
Keratoepithelin),  which  consists  of  four  tandem  repeat
domains of 140 residues and a COOH-terminal Arg-Gly-Asp
(RGD)  motif.  The  protein  has  a  remarkable  sequence
similarity to the Drosophila melanogaster axonal guidance
molecule, fasciclin 1 (FAS1) [25] (Figure 4). The four FAS1
domains in human TGFBIp correspond to amino acids 134–
236 (FAS1–1), 242–372 (FAS1–2), 373–501 (FAS1–3), and
502–632 (FAS1–4). The p.G623D mutation is located in the
fourth internal domain of TGFBIp. The glycine residue is
highly  conserved  in  several  species  including  Pan
troglodytes,Canis familiaris,Mus musculus,Macaca mulatta,
and Gallus gallus (Figure 4), suggesting that a mutation in this
region may have a severe consequence in the structure and/or
the function of the protein. Moreover, in 2003, Clout NJ et al.
[26] made a model of the FAS1 domain 4 of βig-h and found
that  Gly623  is  located  in  β7.  The  mutation  of  glycine  to
aspartic acid is incompatible with correct folding of FAS1,
and the mutated G623D βig-h3 is unlikely to be secreted.
Several  factors  such  as  advanced  stage  disease,  age,
environmental factors, and modifier genes contribute to the
intrafamily  and  interfamily  variability  in  phenotypic
expression. Thus, a precise diagnosis of corneal disorders
cannot  rely  solely  on  the  clinical  and  histopathological
features. In this study, we provide clinical and molecular
Figure  4.  Schematic  diagram  of  TGFBI.  A:  A  diagram  of
recombinant ßIG-H3 proteins is illustrated. Black and gray boxes
indicate the highly conserved sequences of each repeated domain.
The RGD motif is shown as an open box. Mutations of TGFBI
associated with RBCD occur at amino acids 124, 555, 540, and 623
are indicated by arrows. B: The alignment of TGFBI sequences in
diverse species is shown. The glycine is conserved in TGFBI proteins
from several species.
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1300evidence  supporting  the  occurrence  of  a  distinct  RBCD
phenotype  attributable  to  the  TGFBI  p.G623D  mutation.
These  data  enlarge  the  range  of  phenotypic  variability  of
RBCD associated with mutations in TGFBI and expand our
knowledge of RBCD in Chinese patients. These findings may
be helpful for improving the diagnosis of corneal dystrophies
associated with atypical clinical features.
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